We have previously shown that 12 days of high-dose calcineurin inhibition induced tolerance in MHC inbred miniature swine receiving MHC-mismatched lung, kidney, or co-transplanted heart/kidney allografts. However, if lung grafts were procured from donation after brain death (DBD), and transplanted alone, they were rejected within 19-45 days. Here, we investigated whether donor brain death with or without allograft ischemia would also prevent tolerance induction in kidney or heart/kidney recipients. Four kidney recipients treated with 12 days of calcineurin inhibition received organs from donors rendered brain dead for 4 hours. Six heart/kidney recipients also treated with calcineurin inhibition received organs from donors rendered brain dead for 4 hours, 8 hours, or 4 hours with 4 additional hours of cold storage. In contrast to lung allograft recipients, all isolated kidney or heart/kidney recipients that received organs from DBD donors achieved long-term survival (>100 days) without histologic evidence of rejection. Proinflammatory cytokine gene expression was upregulated in lungs and hearts, but not kidney allografts, after brain death. These data suggest that the deleterious effects of brain death and ischemia on tolerance induction are organ-specific, which has implications for the application of tolerance to clinical transplantation.
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| INTRODUC TI ON
Clinical studies have demonstrated that long-term tolerance can be achieved in human recipients of kidney allografts. 1 However, kidney allografts transplanted into these patients were procured from living-related donors and transplanted with short ischemic times. Thus the donor organs had not been exposed to the highly inflammatory milieu consequent to brain death, and nor had they been exposed to prolonged ischemia. Given the deleterious effects of brain death and ischemia on organ function and allograft survival, 2 it is necessary to understand how brain death and ischemia affect tolerance induction before extending tolerance protocols proven successful in recipients of living-donor organs to recipients of cadaveric-donor organs.
Our laboratory has previously studied the effects of brain death in a lung transplantation model using MHC-inbred miniature swine.
We showed that a 12-day course of high-dose tacrolimus induced long-term tolerance in recipients of fully MHC-mismatched lung allografts procured from healthy, non-brain-dead donors. However, when lung allografts were procured from donors rendered brain dead and mechanically ventilated for 4 hours before organ procurement, they were all rejected within 45 days. 3 These data confirm, in a preclinical model, that the deleterious effects of brain death in the donor have the potential to render an otherwise successful tolerance protocol ineffective.
In separate tolerance studies using miniature swine, it has been
shown that a 12-day course of high-dose tacrolimus could also induce tolerance in recipients of fully MHC-mismatched kidney allografts, 4 but not of heart allografts. In fact, when isolated heart allografts were transplanted across the same full MHC barrier with the same 12-day course of tacrolimus, they were all rejected within 40 days. 5 However, when heart and kidney allografts from the same MHC-mismatched donor were co-transplanted under a 12-day course of tacrolimus, recipients uniformly became tolerant of both organs. 5 These studies demonstrate that the ability of a particular tolerance protocol to induce long-term unresponsiveness is organ-specific.
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Given the striking organ-specific differences we have observed in the ability of tolerance-induction protocols to achieve immune unresponsiveness, we asked whether the effects of brain death and ischemia on tolerance induction would also differ depending on the organ transplanted. Here we show that in contrast to lung allograft recipients, donor brain death and prolonged organ ischemia did not prevent tolerance induction in isolated kidney or heart plus kidney allograft recipients.
| MATERIAL AND ME THODS

| Animals
Transplant donors and recipients were selected from our herd of MHC inbred miniature swine (age 3-6 months, weight 15-50 kg). 
| Experimental groups
Eight miniature swine received combined heart and kidney allo- 
| Heart and kidney transplantation
Recipients underwent bilateral nephrectomy. The aorta and inferior vena cava were used for end-to-side arterial and venous anastomoses for both the heart and kidney, with the heart placed on the right and the kidney on the left in cases of heart/kidney co-transplantation.
A vesicoureteral anastomosis was performed as part of the kidney implantation. 
| Renal artery clamping
The laparotomy was re-opened and, after heparin administration (200 units/kg), the renal artery was clamped for 80 minutes with a bulldog clamp. Twenty-four hours after clamping, a kidney biopsy was performed to evaluate the degree of ischemic injury. Kidney-injury molecule-1 (KIM-1), a transmembrane protein that is specifically upregulated in injured proximal tubular epithelial cells was used to assess the degree of ischemic renal injury. 
| Skin grafting
Split-thickness skin grafts were placed on the dorsum of long-term tolerant recipients in Group 4. Animals received fresh (self: SLA cc ) or frozen (donor: SLA dd , third party: SLA ll ) skin grafts.
| Immunosuppression and rejection monitoring
Tacrolimus (Haorui Pharma-Chem Inc., Irvine, CA) was administered as a continuous infusion at a dose of 0.08-0.20 mg/kg (target trough level of 30-50 ng/ml) for 12 consecutive days, starting on the day of transplantation. Cyclosporine was given as a daily intravenous infusion over 1 hour (13 to 16 mg/kg/day with target levels 400 to 800 ng/mL) for 12 consecutive days, starting on the day of transplantation. Cardiac allograft rejection was defined by loss of a ventricular impulse on palpation and/or the lack of ventricular contraction on echocardiography. Renal allograft rejection was defined as sustained rise in serum creatinine to >10 mg/dL and/or uremia.
| Histopathological examination
Scoring of acute rejection on cardiac allograft biopsies was based on the International Society for Heart and Lung Transplantation System. 10 Acute rejection in kidney allograft biopsies was scored according to the Banff classification.
11 Some kidney samples were also stained with an anti-mouse/rat FoxP3 antibody (clone: FJK-16s, eBioscience, Inc., San Diego, CA).
| Cell-mediated lympholysis (CML) assay
Effector cells were incubated with target cells at effector/target ratios 
| Mixed lymphocyte reaction (MLR) assay
| Flow cytometry
The presence of anti-donor immunoglobulin (IgM and IgG) in the serum of experimental swine was examined by flow cytometry using a Becton Dickinson FACScalibur (Sunnyvale, CA) as described previously. 
| Immunofluorescence staining for KIM-1
Tissue from a kidney biopsy performed 24 hours after renal artery clamping was stained with the anti-pig-KIM-1 antibody as described previously. 
| Quantitative PCR
Kidney, lung, and heart biopsy specimens obtained before and after brain death were submerged in RNAlater (Qiagen, Valencia, CA) and snap-frozen in liquid nitrogen. RNA was isolated from tissue (Qiagen RNeasy Mini Kit) and used to derive first-strand complementary DNA (Invitrogen cDNA Synthesis Kit). Fold-change difference was calculated using the double-delta Ct method, and all samples were normalized to GAPDH. Quantitative polymerase chain reaction (qPCR) primers were synthesized based on previously published reports of swine-specific assays for IL-1, IL-6, tumor necrosis factor α (TNF-α), interferon γ (IFN-γ), and GAPDH. 13 
| RE SULTS
| Donor brain death did not prevent tolerance induction in recipients of co-transplanted heart and kidney allografts or isolated kidney allografts
We have previously demonstrated that MHC-mismatched recipients of co-transplanted heart/kidney allografts from the same healthy, non-brain-dead donors all became tolerant of their allografts after a 12-day course of tacrolimus and survived long term. 5 Table 1 shows that long-term, stable tolerance was still observed in uncomplicated recipients, which received fully MHCdisparate heart and kidney allografts from donors rendered brain dead for 4 hours (Group 1) or for 8 hours (Group 2) before organ TA B L E 1 Graft survival and histology of heart-kidney and isolated kidney recipients Table 1 ).
The kidney allografts in these recipients all maintained normal function, as evidenced by serial creatinine levels, despite the finding of a variable mononuclear cellular infiltrate classified as Banff borderline or T cell-mediated rejection I (TCMR I) ( Figure S1B ). The infiltrates often formed organized aggregates around arterioles and small arteries rich in FoxP3+ cells ( Figure S1C ) similar to the T regrich organized lymphoid structures (TOLS) that we have observed in spontaneously accepted murine kidney allografts. 14 TOLS were seen as early as 16 days (#21505) and were present in 10 of 11 allograft kidneys at 3 months (Table 1 ), but they were not observed in the heart allografts. Donor brain death had no effect on recipients of isolated kidney allografts, as long-term stable tolerance was also observed in all cyclosporine-treated recipients receiving class I disparate kidney allografts from donors rendered brain dead for 4 hours ( Isolated cardiac allografts were not tested in this brain death study, as hearts from non-brain-dead donors were all rejected within 40 days. 
| Comparison of donor brain death effects in recipients of MHC disparate heart/kidney versus lung allografts
To demonstrate the organ-specific effects of brain death on tolerance induction, we compared the survival times of recipients who were co-transplanted with heart/kidney allografts from brain dead donors to recipients of brain-dead lung allografts (data published previously 3 ). In this comparison, all brain-dead allografts were retrieved 4 hours after intracerebral injury and all allografts were transplanted across a full MHC barrier with the same 12-day course of tacrolimus. Figure 2 shows the clear organ-specific differences in the effects of brain death on tolerance; recipients of lungs from donations after brain death all rejected by postoperative day 45, whereas recipients of kidneys or heart/kidney allografts from these donors survived long term.
| Organ-specific changes in tissue cytokine gene expression after brain death
To determine the inflammatory effects of brain death, we measured the change in cytokine gene expression of Toll-like receptor 2 (TLR2), TLR4, IL-1, IL-6, TNF α, and IFN-γ in donor organs. Kidney, lung, and heart tissue was collected from animals (n = 4 for kidney, n = 3 for lung, n = 2 for heart) before and 4 hours after induction of brain death. qPCR was performed and fold change in gene expression was calculated before normalizing to GAPDH. There was little change in RNA levels of cytokine gene expression in the kidneys ( Figure 3A ). In contrast, substantial increases in RNA for IL-1 and IL-6 were observed in 2 of 3 lungs and in 2 of 2 hearts after brain death ( Figure 3B , C).
| Cold ischemia in addition to brain death did not prevent the induction of tolerance of heart and kidney allografts
When the heart and kidneys were exposed to a 3-to 4-hour period of cold ischemia in addition to the 4-hour period of brain death, longterm stable tolerance was still achieved (Table 1 , Group 3). Serial heart biopsies showed no rejection and in vitro assays revealed no anti-donor T or B cell responses after 3 months (Table 1 ). The only difference noted in this group was the cardiac allograft's greater susceptibility to ventricular arrhythmia after reperfusion.
| Warm ischemic renal injury induced by renal artery clamping did not prevent the induction of tolerance
Two additional heart/kidney transplants were performed using organs from healthy, non-brain-dead donors that were intentionally subjected F I G U R E 2 Donor brain death effects in recipients of heart/ kidney versus lung allografts. Survival times of brain dead heart and kidney allograft recipients (solid line) are compared to the survival times of non-brain-dead lung allograft recipients (dotted line) and brain-dead lung allograft recipients (dashed line). The lung allograft data were published previously
to warm ischemia by returning the recipients to the operating room on POD 2 to undergo in situ donor renal artery clamping for 80 minutes (Table 1 , Group 4). This resulted in a sharp increase in serum creatinine in both recipients, with levels peaking between 4 and 6 mg/dL 72 hours after the ischemic insult. However, creatinine levels gradually decreased to baseline levels over a period of 2 weeks. Kidney biopsies performed 24 hours after clamping and stained for KIM-1 confirmed that the renal tubule epithelium had sustained an ischemic injury (compare Figure S1D , E). Despite this extended period of warm ischemia with documented tubular injury, both recipients accepted the heart and kidney allografts long term and showed no anti-donor T cell ( Figure 1B, C) or B cell responses. Serial biopsies showed no signs of cellular rejection in the heart ( Figure S1F ) and minimal infiltrate in the kidney (Table 1) .
Donor-specific (SLA dd ) and third-party (SLA ll ) skin grafts were placed on the Group 4 recipients on PODs 97 (#21736) and 98 (#21420). The third-party skin grafts were rejected within 10 days; however, the donor-specific skin grafts survived to days 35 (#21420) and 62 (#21736). Of note, serial biopsies of the heart and kidney allografts in both recipients showed no evidence of rejection well after rejection of donor skin (over 60 days). This finding demonstrates that even after an ischemic insult, the tolerogenic kidney can induce and maintain a robust state of unresponsiveness.
| D ISCUSS I ON
The recent successes achieved in inducing tolerance in human recipients of living-donor kidney allografts has prompted investigators to consider applying the same protocols to recipients of organs procured from brain-dead donors.* However, there is little experimental literature to guide this new initiative, as most small-and large-animal tolerance studies have used organs from healthy, non-brain-dead donors transplanted under optimal circumstances with very short ischemic times. This concern is heightened by our previous report demonstrating that donor brain death can render ineffective a tolerance protocol that was otherwise successful in recipients receiving lungs from healthy, non-brain-dead donors ( Figure 2 ).
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Previously documented organ-specific differences in tolerance induction 4,5 led us to consider whether the effects of brain death and ischemia on tolerance induction would also differ depending on the organ transplanted. Here we demonstrate that, in contrast to lung allograft recipients, brain death and ischemia (cold and warm)
did not prevent tolerance induction in isolated kidney or heart plus kidney recipients. These findings suggest that, like tolerance, the effects of donor brain death and ischemia vary with the organ transplanted.
The effect of donor brain death and organ ischemia on organ quality has been studied extensively; however, investigations into the effect of brain death and ischemia on tolerance induction are limited. Francuski et al 16 showed that donor brain death affected the long-term function and histology of rat kidneys transplanted into recipients treated with 10 days of CyA and anti-CD4 mAb therapy, but it did not affect overall graft survival. The same group demonstrated that extended cold ischemia did not interfere with the induction of rat kidney allograft tolerance using anti-CD4 mAb treatment. 17 These findings are in line with our results in porcine recipients of isolated kidney allograft. However, to our knowledge, comparable studies evaluating the effects of brain death on tolerance in heart or lung allograft recipients have not been performed.
Our finding that isolated kidney recipients and heart/kidney recipients were spared from the deleterious effects of brain death and ischemia (in contrast to lung allografts) suggests an organ-specific mechanism that has not been described previously. These results extend our earlier studies using non-brain-dead donors by showing that not only are kidney allografts able to confer tolerance on otherwise tolerance-resistant hearts, 5 but also that they possess an intrinsic ability to counter the deleterious effects of brain death and ischemia on tolerance induction.
To investigate the mechanisms underlying these organ-specific differences, we measured the changes in gene expression of TLR2, F I G U R E 3 Change in tissue gene expression after brain death. qPCR was performed on RNA isolated from kidney (A), lung (B), and heart (C) tissue collected from animals before and 4 hours after induction of brain death. Fold change difference was calculated using the double delta Ct method, and all samples were normalized to GAPDH TLR4, IL-1, IL-6, TNF-α, and IFN-γ, which occurred in kidney, heart, and lung tissue after 4 hours of brain death. Little change in RNA levels of cytokine gene expression was observed in kidney tissue but substantial increases in RNA for IL-1 and IL-6 were observed in lung and heart tissue after brain death. These organ-specific differences in gene expression following brain death are consistent with previous reports in the literature 18, 19 These findings suggest that the differential effects observed after brain death observed in our study result from organ-specific In summary, our results show that the deleterious effects of brain death and ischemia on tolerance induction differ depending on the organ transplanted, with kidney being more resistant to the effects of brain death and ischemia than lungs. Moreover, kidney allografts from donors after brain death can extend their protective effects to co-transplanted heart allografts from donors after brain death. 
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